Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 4 Time to thrombosis according to therapy

From: Acquired activated protein C resistance and thrombosis in multiple myeloma patients

Patient Therapy Time to thrombosis Months APC-R Yes/Not
1 TD 6 Yes
2 TD 7 Yes
3 TD 8 Yes
4 TD 6 Yes
5 TD 6 Not
6 VAD-T 3 Not
7 VAD 2 Not
8 VAD 2 Not
  1. p value 0.007 time to thrombosis between TD and VAD therapy.
  2. TD: Thalidomide plus dexamethasone, VAD; Vincristine, Doxorubicin and Dexamethasone; VAD-T: VAD plus thalidomide; APC-R Acquired activated protein C resistance.